Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Symbiosis Capital Management

Status
Global HQ
Dublin, Ireland
Countries of investment
    Investment stages
      Industries
        About
        SymBiosis Capital Management is a biotechnology VC firm investing in cutting-edge biotherapeutics for serious diseases, including novel biologics and precision therapies, to revolutionize healthcare.
        Min check size
        -
        Max check size
        -
        Fund size
        NPS

        Investment Thesis

        Lead investor
        Co Invest
        Number of exits
        Preferred contact method

        Manager's Experience

        Bringing extensive expertise in early-stage investments, the fund manager has a robust portfolio spanning the technology and healthcare sectors across North America and Europe. With a strategic operator-first approach, they have successfully executed over 30 deals, demonstrating a keen ability to identify high-potential startups. Noteworthy exits include several high-growth companies that have positioned themselves as leaders in their respective fields. Their investment style emphasizes a data-driven methodology, ensuring informed decision-making throughout the investment process.

        Symbiosis Capital Management Contacts Information

        Fund number
        Vintage Year
        Net Internal Rate of Return
        Investment Multiple
        Capital Allocation
        Management Fee
        Carried Interest
        AUM
        Follow-on Investments
        Graduation Rate
        Write-Off Ratio
        Last profile update timestamp